High Free Cash Flow Stocks
SAN.PA is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
SANOFI (SAN.PA) Stock Price & Overview
EPA:SAN • FR0000120578
Current stock price
82.58 EUR
-0.29 (-0.35%)
Last:
The current stock price of SAN.PA is 82.58 EUR. Today SAN.PA is down by -0.35%. In the past month the price increased by 6.24%. In the past year, price decreased by -13.98%.
SAN.PA Key Statistics
52-Week Range74.85 - 98.36
Current SAN.PA stock price positioned within its 52-week range.
1-Month Range74.85 - 83.77
Current SAN.PA stock price positioned within its 1-month range.
- Market Cap
- 199.437B
- P/E
- 10.56
- Fwd P/E
- 9.74
- EPS (TTM)
- 7.82
- Dividend Yield
- 5.08%
SAN.PA Stock Performance
Today
-0.35%
1 Week
+1.76%
1 Month
+6.24%
3 Months
+0.32%
Longer-term
6 Months -4.86%
1 Year -13.98%
2 Years -11.28%
3 Years -17.42%
5 Years -5.37%
10 Years +14.52%
SAN.PA Stock Chart
SAN.PA Stock Screens
SAN.PA currently appears in the following ChartMill screener lists.
SAN.PA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to SAN.PA. When comparing the yearly performance of all stocks, SAN.PA is a bad performer in the overall market: 82.14% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
SAN.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA. SAN.PA has an average financial health and profitability rating.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SAN.PA Earnings
On January 29, 2026 SAN.PA reported an EPS of 1.53 and a revenue of 11.30B. The company beat EPS expectations (4.58% surprise) and missed revenue expectations (-2.08% surprise).
Next Earnings DateApr 23, 2026
Last Earnings DateJan 29, 2026
PeriodQ4 / 2025
EPS Reported€1.53
Revenue Reported11.303B
EPS Surprise 4.58%
Revenue Surprise -2.08%
SAN.PA Forecast & Estimates
30 analysts have analysed SAN.PA and the average price target is 97.97 EUR. This implies a price increase of 18.64% is expected in the next year compared to the current price of 82.58.
For the next year, analysts expect an EPS growth of 8.41% and a revenue growth 6.58% for SAN.PA
Analysts
Analysts76
Price Target97.97 (18.64%)
EPS Next Y8.41%
Revenue Next Year6.58%
SAN.PA Groups
Sector & Classification
SAN.PA Financial Highlights
Over the last trailing twelve months SAN.PA reported a non-GAAP Earnings per Share(EPS) of 7.82. The EPS increased by 1.82% compared to the year before.
Income Statements
Revenue(TTM)70.49B
Net Income(TTM)12.49B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 17.71% | ||
| ROA | 9.85% | ||
| ROE | 17.49% | ||
| Debt/Equity | 0.22 |
Chartmill High Growth Momentum
EPS Q2Q%16.79%
Sales Q2Q%7%
EPS 1Y (TTM)1.82%
Revenue 1Y (TTM)5.29%
SAN.PA Ownership
Ownership
Inst Owners46.23%
Shares2.42B
Float2.14B
Ins Owners0.02%
Short Float %N/A
Short RatioN/A
SAN.PA Competitors/Peers
The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.77 | 200.017B | ||
| SNW | SANOFI | 9.73 | 199.316B | ||
| UCB | UCB SA | 25.72 | 51.448B | ||
| UNC | UCB SA | 25.39 | 50.806B | ||
| MRK | MERCK KGAA | 13.28 | 47.739B | ||
| 1BAYN | BAYER AG-REG | 8.59 | 39.493B | ||
| BAYN | BAYER AG-REG | 8.48 | 38.997B | ||
| IPN | IPSEN | 13.73 | 14.038B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.45 | 10.457B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.77B | ||
| VIRP | VIRBAC SA | 16.3 | 2.945B | ||
| DMP | DERMAPHARM HOLDING SE | 18.77 | 2.544B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About SAN.PA
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 76,493 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Company Info
IPO: 2002-07-01
SANOFI
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE FR
Employees: 82878
Phone: 33153774000
SANOFI / SAN.PA FAQ
Can you describe the business of SANOFI?
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 76,493 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Can you provide the latest stock price for SANOFI?
The current stock price of SAN.PA is 82.58 EUR. The price decreased by -0.35% in the last trading session.
Does SANOFI pay dividends?
SANOFI (SAN.PA) has a dividend yield of 5.08%. The yearly dividend amount is currently 3.79.
How is the ChartMill rating for SANOFI?
SAN.PA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How many employees does SANOFI have?
SANOFI (SAN.PA) currently has 82878 employees.
What is the market capitalization of SAN stock?
SANOFI (SAN.PA) has a market capitalization of 199.44B EUR. This makes SAN.PA a Large Cap stock.
Who owns SANOFI?
You can find the ownership structure of SANOFI (SAN.PA) on the Ownership tab.